Overexpression of antiapoptotic proteins such as BCL2, BCL2L1/BCL-XL, and MCL1, on the other hand, negatively correlates with response to cisplatin in ovarian or head and neck squamous cell carcinoma (HNSCC) patients (Supplementary Table S1). Here, BCL2 is linked to head and neck squamous cell carcinoma.